Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 59762-1061

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 59762-1061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diphenoxylate 01)

FDA Label Image

Chemical Structure (Diphenoxylate 02)

FDA Label Image

Greenstone Logo (Diphenoxylate 03)

Greenstone Logo (Diphenoxylate 03)
This is a description of the Greenstone® brand, which is distributed by Greenstone LLC from Peapack, NJ 07977.*
FDA Label Image

Principal Display Panel (2.5 mg/0.025 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg/0.025 mg Tablet Bottle Label)
This is a medication warning label for a bottle of tablets containing diphenoxylate hydrochloride and atropine sulfate USP. It warns against exceeding the recommended dose, keeping out of reach of children, and that the tablets may be habit-forming. The tablets are not recommended for children under six years of age. The label also provides the manufacturer's information, distribution information, and the quantity of tablets (100).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.